Announcement
12 Jul 2021
India has announced a customs duty exemption on the imports of raw materials for manufacturing the drug Amphotericin-B and COVID-19 test kits.
Source
Number of interventions
2
1 certainly harmful
0 likely harmful
1 liberalising
Implementation date
12 Jul 2021
Revocation date:
30 Sep 2021
On 12 July 2021, the Indian Ministry of Finance through Notification No. 35/2021-Customs announced an import duty exemption on raw materials for the manufacture of the drug Amphotericin B and of CO...
Implementation date
12 Jul 2021
Revocation date:
30 Sep 2021
On 12 July 2021, the Indian Ministry of Finance through Notification No. 35/2021-Customs announced a temporary customs duty exemption on certain Active Pharmaceutical Ingredients (APIs) o...
See all
This state act is not part of any Thread yet.